JulieRaniNangiaMD

Oncology • Houston, TX

Breast Cancer, Hematologic Oncology

Assistant Professor, Medicine, Baylor College of Medicine

Join to view full profile

Dr. Nangia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Nangia's full profile

Already have an account?

Office
7200 Cambridge St
7th floor
Houston, TX 77030
Phone+1 713-798-1999

Fax+1 713-798-1910
Is this information wrong?

Education & Training

Rush University Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2004 - 2007
University of Missouri Kansas City School of MedicineClass of 2004

Certifications & Licensure

TX State Medical License 2010 - 2026
LA State Medical License 2022 - 2023
IL State Medical License 2007 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients Start of enrollment: 2004 Sep 01
Completed
Phase 2
Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer Start of enrollment: 2007 Dec 01
Completed
Phase 2
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors Start of enrollment: 2013 May 01
Completed
Phase 2
High Dose Vitamin D vs Standard Dose Vitamin D Study Start of enrollment: 2013 Dec 01
Terminated
Phase 2
CRIZENT: Crizotinib and Sunitinib in Metastatic Breast Cancer Start of enrollment: 2014 Jun 01
Terminated
Phase 1
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Recruiting
Phase 3
Niraparib + Dostarlimab In BRCA Mutated Breast Cancer Start of enrollment: 2020 Dec 18
Recruiting
Phase 2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

2 citations
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.
Jamunarani Veeraraghavan, Carolina Gutierrez, Carmine De Angelis, Robert Davis, Tao Wang, Tomas Pascual, Pier Selenica, Katherine Sanchez, Hiroaki Nitta, Monesh Kapadi...> ;Clinical Cancer Research. 2023 Aug 15
17 citations
Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts.
Siri H Strand, Belén Rivero-Gutiérrez, Kathleen E Houlahan, Jose A Seoane, Lorraine M King, Tyler Risom, Lunden A Simpson, Sujay Vennam, Aziz Khan, Luis Cisneros, Timo...> ;Cancer Cell. 2022 Dec 12
18 citations
Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer.
Meenakshi Anurag, Eric J Jaehnig, Karsten Krug, Jonathan T Lei, Erik J Bergstrom, Beom-Jun Kim, Tanmayi D Vashist, Anh Minh Tran Huynh, Yongchao Dou, Xuxu Gou, Chen Hu...> ;Cancer Discovery. 2022 Nov 2
Prognostic Impact of Radiation Therapy in Pure Mucinous Breast Carcinoma.
Neil Chevli, Kaidi Wang, Waqar Haque, Mary R Schwartz, Julie Nangia, Jennifer Sasaki, Andrew M Farach, Sandra S Hatch, E Brian Butler, Bin S Teh> ;Clinical Breast Cancer. 2022 Oct 1
7 citations
Elacestrant and the Promise of Oral SERDs.
Katherine G Sanchez, Julie R Nangia, Rachel Schiff, Mothaffar F Rimawi> ;Journal of Clinical Oncology. 2022 Oct 1
13 citations
The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer.
Cynthia X Ma, Jingqin Luo, Rachel A Freedman, Timothy J Pluard, Julie R Nangia, Janice Lu, Frances Valdez-Albini, Melody Cobleigh, Jason M Jones, Nancy U Lin, Eric P W...> ;Clinical Cancer Research. 2022 Apr 1
6 citations
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancer.
Valentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, Ayumi Watanabe, Ifigeneia Tzannou, Yovana Velazquez, Matthew French-Kim, Wingchi Leung, Suhasini Lulla, Catheri...> ;Therapeutic Advances in Medical Oncology. 2022 Jan 1
1 citations
Breast Cancer Prevention: Where Are We?
Julie R. Nangia, Mothaffar F. Rimawi> ;JCO Oncology Practice. 2021 Oct 7
2 citations
Dose-reduced trastuzumab deruxtecan can be safely used in liver failure and active leptomeningeal metastases.
Nicole Higashiyama, Julie R. Nangia, Maryam Nemati Shafaee, Nan Chen, Binu Liz Michael, Mothaffar F. Rimawi, Valentina Hoyos> ;Current Problems in Cancer. Case Reports. 2020 Dec 15
74 citations
TBCRC 032 IB/II Multicenter Study: Molecular insights to AR antagonist and PI3K inhibitor efficacy in patients with AR+ metastatic triple-negative breast cancer
Brian D. Lehmann, Vandana G Abramson, Melinda E. Sanders, Erica L. Mayer, Tufia C. Haddad, Rita Nanda, Catherine Van Poznak, Anna Maria Storniolo, Julie R. Nangia, Pau...> ;Clinical Cancer Research. 2020 May 1
15 citations
Clinical presentation, national practice patterns, and outcomes of breast adenomyoepithelioma.
Waqar Haque, Vivek Verma, Vickie Suzanne Klimberg, Julie R. Nangia, Mary R. Schwartz, Edward Brian Butler, Bin S. Teh> ;The Breast Journal. 2020 Apr 1
15 citations
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022
Rachel A. Freedman, Rebecca Gelman, Nathalie Y. R. Agar, Sandro Santagata, Elizabeth C. Randall, Begoña Gimenez-Cassina Lopez, Roisin M. Connolly, Ian F. Dunn, Catheri...> ;Clinical Breast Cancer. 2020 Apr 1
31 citations
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer.
Mothaffar F. Rimawi, Polly A. Niravath, Tao Wang, Brent N. Rexer, Andres Forero, Antonio C. Wolff, Rita Nanda, Anna Maria Storniolo, Ian E. Krop, Matthew P. Goetz, Jul...> ;Clinical Cancer Research. 2020 Feb 15
220 citations
TBCRC 022: A phase II trial of neratinib and capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases
Rachel A. Freedman, Rebecca Gelman, Carey K. Anders, Michelle E. Melisko, Heather A. Parsons, Anne Cropp, Kelly Silvestri, Christine M Cotter, Kathryn P. Componeschi, ...> ;Journal of Clinical Oncology. 2019 Mar 12
12 citations
Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia
Polly A. Niravath, Susan G. Hilsenbeck, Tao Wang, Sao Jiralerspong, Julie R. Nangia, Anne Pavlick, Foluso O. Ademuyiwa, Ashley Frith, Cynthia X. Ma, Haeseong Park, Car...> ;Breast Cancer Research and Treatment. 2019 Jun 19
42 citations
Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.
Alyssa N. Johnston, Wen Bu, Sarah Hein, S. Garcia, Laura Camacho, Lei Xue, Lanfang Qin, Chandandeep Nagi, SG Hilsenbeck, J. Kapali, K. Podsypanina, J. Nangia, Yi Li> ;Breast Cancer Research. 2018 May 19
44 citations
Hair disorders in patients with cancer
Azael Freites-Martinez, Jerry Shapiro, Shari Goldfarb, Julie R. Nangia, Joaquin J. Jimenez, Ralf Paus, Mario E. Lacouture> ;Journal of the American Academy of Dermatology. 2019 May 1
13 citations
A Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
Ayca Gucalp, Xi Kathy Zhou, Elise D. Cook, Judy Garber, Katherine D. Crew, Julie R. Nangia, Priya Bhardwaj, Dilip Giri, Olivier Elemento, Akanksha Verma, Hanhan Wang, ...> ;Cancer Prevention Research. 2018 Apr 1
10 citations
Quality of Life Matters: It Is Time to Integrate Scalp Cooling in Routine Clinical Practice
Julie R. Nangia> ;Journal of Oncology Practice. 2018 Feb 15
126 citations
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial
Julie R. Nangia, Tao Wang, Cynthia Osborne, Polly A. Niravath, Kristen Otte, Steven W. Papish, Frankie A. Holmes, Jame Abraham, Mario E. Lacouture, Jay Courtright, Ric...> ;JAMA. 2017 Feb 14
47 citations
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-...
Andres Forero-Torres, Katherine E. Varley, Vandana G. Abramson, Yufeng Li, Christos Vaklavas, Nan Lin, Minetta C. Liu, Hope S. Rugo, Rita Nanda, Anna Maria Storniolo, ...> ;Clinical Cancer Research. 2015 Jun 15
67 citations
Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
Costanza Paoletti, Yufeng Li, Maria C. Muñiz, Kelley M. Kidwell, Kimberly Aung, Dafydd G. Thomas, Martha E. Brown, Vandana G. Abramson, William J. Irvin, Nan Lin, Mine...> ;Clinical Cancer Research. 2015 Jun 15
5 citations
Jejunal intussusception due to malignant phyllodes tumor of the breast.
Mehmet Asim Bilen, Rodolfo Laucirica, Mothaffar F. Rimawi, Julie R. Nangia, Gerald S. Cyprus> ;Clinical Breast Cancer. 2012 Jun 1
4 citations
Denosumab for treatment of breast cancer bone metastases and beyond.
Julie R. Nangia, Joseph D. Ma, Christine M. Nguyen, Margaret A.S. Mendes, Meghana V. Trivedi> ;Expert Opinion on Biological Therapy. 2012 Mar 13
4 citations
Multiple myeloma with multiple extramedullary plasmacytomas.
Julie R. Nangia, Arti A Lakhani, Jerome Loew, Stephanie A. Gregory> ;Clinical Advances in Hematology & Oncology. 2011 Aug 1
Join now to see all

Press Mentions

Know Your Threat for Breast Most CancersOctober 31st, 2022
Debunking Myths About CancerJune 10th, 2022
Olivia Newton-John, 73, Rereleases Vinyl Edition of 1981 Hit Album, ‘Physical:’ Star Is Thriving While Surviving Stage 4 CancerMay 27th, 2022
Join now to see all

Hospital Affiliations

St. Luke's Health - Baylor St. Luke's Medical CenterHouston, Texas
Harris Health SystemHouston, Texas
Baylor McNair CampusHouston, Texas